Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ: AGIO · Real-Time Price · USD

27.48

-0.68 (-2.41%)

At close: May 4, 2026, 4:00 PM EDT

27.56

+0.08 (0.29%)

After-hours: May 4, 2026, 4:10 PM EDT

Agios Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	113.6	89.13	76.25	88.21	139.26	203.13
Short-Term Investments	623.44	765.3	817.46	688.72	643.86	816.89
Cash & Short-Term Investments	737.04	854.43	893.71	776.93	783.12	1,020
Cash Growth	-17.50%	-4.40%	15.03%	-0.79%	-23.23%	78.04%
Accounts Receivable	16.13	10.58	4.11	2.81	2.21	-
Other Receivables	-	-	-	-	-	4.38
Total Trade Receivables	16.13	10.58	4.11	2.81	2.21	4.38
Inventory	35.09	32.92	27.62	19.08	8.49	-
Other Current Assets	46.59	44.13	40.17	35.02	38.96	39.84
Total Current Assets	834.84	942.05	965.6	833.84	832.77	1,064
Net Property, Plant & Equipment	37.76	41.23	54.55	69.79	88.12	104.23
Long-Term Investments	308.45	310.01	638.32	29.44	313.87	266.38
Other Long-Term Assets	3.93	3.93	4.72	4.06	3.96	2.9
Total Assets	1,185	1,297	1,663	937.12	1,239	1,438
Accounts Payable	13.75	18.36	16.64	9.78	18.62	16.7
Accrued Expenses	26.29	45.46	46.86	43.17	30.35	31.97
Current Portion of Leases	18.81	18.39	16.78	15.01	13.66	11.16
Other Current Liabilities	-	-	0.87	-	-	-
Total Current Liabilities	58.85	82.21	81.16	67.96	62.63	59.83
Long-Term Leases	16.94	21.82	40.21	56.99	72	85.94
Other Long-Term Liabilities	0.09	0.09	0.88	1.16	3.28	-
Total Long-Term Liabilities	17.03	21.91	41.09	58.14	75.28	85.94
Total Liabilities	75.88	104.11	122.24	126.1	137.9	145.76
Common Stock	0.08	0.08	0.07	0.07	0	0.07
Treasury Stock	-802.49	-802.49	-802.49	-802.49	-802.49	-802.49
Additional Paid-in Capital	2,573	2,555	2,494	2,437	2,386	2,334
Accumulated Other Comprehensive Income	-0.31	2.19	-1.52	-0.44	-12.54	-1.2
Retained Earnings	-660.82	-561.71	-148.92	-822.65	-470.56	-238.76
Shareholders' Equity	1,109	1,193	1,541	811.02	1,101	1,292
Total Liabilities & Equity	1,185	1,297	1,663	937.12	1,239	1,438
Total Debt	35.75	40.21	56.99	72	85.66	97.09
Net Cash (Debt)	701.29	814.22	836.72	704.93	697.46	922.92
Net Cash Growth	-13.87%	-2.69%	18.70%	1.07%	-24.43%	97.32%
Net Cash Per Share	12.03	14.04	14.45	12.67	12.73	15.27
Book Value	1,109	1,193	1,541	811.02	1,101	1,292
Book Value Per Share	19.02	20.58	26.62	14.57	20.09	21.37
Tangible Book Value	1,109	1,193	1,541	811.02	1,101	1,292
Tangible Book Value Per Share	19.02	20.58	26.62	14.57	20.09	21.37

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q